OT1-11-02: PRAEGNANT -真实世界证据,转化研究,大数据和智能数据:优化辅助和晚期/转移环境中肿瘤医疗质量的前瞻性学术转化研究网络(NCT02338167)

V. Müller, J. Huober, B. Volz, F. Overkamp, H. Kolberg, P. Hadji, L. Haeberle, J. Ettl, A. Hartkopf, M. Lux, D. Lüftner, M. Wallwiener, F. Taran, M. Beckmann, E. Belleville, P. Wimberger, C. Hielscher, M. Geberth, J. Lermann, A. Abenhardt, C. Kurbacher, R. Wuerstlein, C. Thomssen, M. Untch, W. Janni, T. Fehm, S. Brucker, D. Wallwiener, A. Schneeweiss, P. Fasching, H. Tesch
{"title":"OT1-11-02: PRAEGNANT -真实世界证据,转化研究,大数据和智能数据:优化辅助和晚期/转移环境中肿瘤医疗质量的前瞻性学术转化研究网络(NCT02338167)","authors":"V. Müller, J. Huober, B. Volz, F. Overkamp, H. Kolberg, P. Hadji, L. Haeberle, J. Ettl, A. Hartkopf, M. Lux, D. Lüftner, M. Wallwiener, F. Taran, M. Beckmann, E. Belleville, P. Wimberger, C. Hielscher, M. Geberth, J. Lermann, A. Abenhardt, C. Kurbacher, R. Wuerstlein, C. Thomssen, M. Untch, W. Janni, T. Fehm, S. Brucker, D. Wallwiener, A. Schneeweiss, P. Fasching, H. Tesch","doi":"10.1158/1538-7445.sabcs18-ot1-11-02","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19476,"journal":{"name":"Ongoing Clinical Trials","volume":"84 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167)\",\"authors\":\"V. Müller, J. Huober, B. Volz, F. Overkamp, H. Kolberg, P. Hadji, L. Haeberle, J. Ettl, A. Hartkopf, M. Lux, D. Lüftner, M. Wallwiener, F. Taran, M. Beckmann, E. Belleville, P. Wimberger, C. Hielscher, M. Geberth, J. Lermann, A. Abenhardt, C. Kurbacher, R. Wuerstlein, C. Thomssen, M. Untch, W. Janni, T. Fehm, S. Brucker, D. Wallwiener, A. Schneeweiss, P. Fasching, H. Tesch\",\"doi\":\"10.1158/1538-7445.sabcs18-ot1-11-02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19476,\"journal\":{\"name\":\"Ongoing Clinical Trials\",\"volume\":\"84 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-02-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ongoing Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1158/1538-7445.sabcs18-ot1-11-02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ongoing Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1538-7445.sabcs18-ot1-11-02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Abstract OT1-11-02: PRAEGNANT - Real world evidence, translational research, big and smart data: A prospective academic translational research network for the optimization of the oncological health care quality in the adjuvant and advanced/ metastatic setting (NCT02338167)
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Abstract OT3-07-01: Efficacy of magnetic resonance-guided high intensity focused ultrasound for the ablation of breast cancer Abstract OT2-03-04: A trial of induction Talazoparib followed by a combination of Talazoparib and Avelumab in advanced breast cancer: The TALAVE study Abstract OT2-04-04: Neoadjuvant HER2-targeted therapy +/- immunotherapy with pembrolizumab (neoHIP): An open label randomized phase 2 trial Abstract OT1-04-02: POSITIVE: A study evaluating pregnancy, disease outcome and safety of interrupting endocrine therapy for premenopausal women with endocrine responsive breast cancer who desire pregnancy (IBCSG 48-14/big 8-13) Abstract OT1-03-01: Phase 1/1b study of novel oral selective estrogen receptor degrader (SERD) LSZ102 in combination with alpelisib (BYL719) in estrogen receptor-positive (ER+), human epidermal growth factor receptor-2–negative (HER2–) advanced breast cancer (ABC) with progression on endocrine thera
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1